Cargando…

Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources

Detalles Bibliográficos
Autores principales: Popov, Todor A., Church, Martin K., Christoff, George, Maurer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820250/
https://www.ncbi.nlm.nih.gov/pubmed/31687062
http://dx.doi.org/10.1016/j.waojou.2019.100079
_version_ 1783463897507823616
author Popov, Todor A.
Church, Martin K.
Christoff, George
Maurer, Marcus
author_facet Popov, Todor A.
Church, Martin K.
Christoff, George
Maurer, Marcus
author_sort Popov, Todor A.
collection PubMed
description
format Online
Article
Text
id pubmed-6820250
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-68202502019-11-04 Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources Popov, Todor A. Church, Martin K. Christoff, George Maurer, Marcus World Allergy Organ J Article World Allergy Organization 2019-10-23 /pmc/articles/PMC6820250/ /pubmed/31687062 http://dx.doi.org/10.1016/j.waojou.2019.100079 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Popov, Todor A.
Church, Martin K.
Christoff, George
Maurer, Marcus
Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
title Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
title_full Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
title_fullStr Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
title_full_unstemmed Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
title_short Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
title_sort angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820250/
https://www.ncbi.nlm.nih.gov/pubmed/31687062
http://dx.doi.org/10.1016/j.waojou.2019.100079
work_keys_str_mv AT popovtodora angioedemaandprescribingofomalizumabforchronicurticariaincountrieswithlimitedfinancialresources
AT churchmartink angioedemaandprescribingofomalizumabforchronicurticariaincountrieswithlimitedfinancialresources
AT christoffgeorge angioedemaandprescribingofomalizumabforchronicurticariaincountrieswithlimitedfinancialresources
AT maurermarcus angioedemaandprescribingofomalizumabforchronicurticariaincountrieswithlimitedfinancialresources